Literature DB >> 17305491

Pharmacokinetic and pharmacodynamic variability: a daunting challenge in drug therapy.

Jiunn H Lin1.   

Abstract

Patients vary considerably in their response to drug therapy. A drug that proves to be pharmacologically effective in some patients at a given dose may be ineffective or even toxic in others. The interindividual variability in drug response represents a major challenge in drug therapy, particularly for drugs with narrow therapeutic index. The intensity and duration of a drug action are determined not only by pharmacokinetic processes, but also by pharmacodynamic processes. Therefore, the variability in drug response is a result of the variability in either pharmacokinetic or pharmacodynamic processes, or a combination of both. The purpose of this paper is to review the sources that contribute to pharmacokinetic and pharmacodynamic variability. Although the main focus will be on the genetic variability, the impact of environmental factors on drug response will also be discussed. Finally, the application and limitation of the concept of personalized medicine will be briefly discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17305491     DOI: 10.2174/138920007779816002

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  12 in total

Review 1.  Phenotyping of Human CYP450 Enzymes by Endobiotics: Current Knowledge and Methodological Approaches.

Authors:  Gaëlle Magliocco; Aurélien Thomas; Jules Desmeules; Youssef Daali
Journal:  Clin Pharmacokinet       Date:  2019-11       Impact factor: 6.447

Review 2.  Pharmacokinetic variability of long-acting stimulants in the treatment of children and adults with attention-deficit hyperactivity disorder.

Authors:  James C Ermer; Ben A Adeyi; Michael L Pucci
Journal:  CNS Drugs       Date:  2010-12       Impact factor: 5.749

3.  Delivered dose: a drug-centric phenotype for chemotherapy dose individualization.

Authors:  Y Bruce Yu
Journal:  Pharm Res       Date:  2009-06-03       Impact factor: 4.200

4.  Immune activation mediated change in alpha-1-acid glycoprotein: impact on total and free lopinavir plasma exposure.

Authors:  Ighovwerha Ofotokun; Jeffrey L Lennox; Molly E Eaton; James C Ritchie; Kirk A Easley; Svetlana E Masalovich; Mary C Long; Edward P Acosta
Journal:  J Clin Pharmacol       Date:  2011-01-05       Impact factor: 3.126

5.  Coffee, caffeine-related genes, and Parkinson's disease: a case-control study.

Authors:  Maurizio F Facheris; Nicole K Schneider; Timothy G Lesnick; Mariza de Andrade; Julie M Cunningham; Walter A Rocca; Demetrius M Maraganore
Journal:  Mov Disord       Date:  2008-10-30       Impact factor: 10.338

Review 6.  Suggestions for Model-Informed Precision Dosing to Optimize Neonatal Drug Therapy.

Authors:  Joshua C Euteneuer; Suyog Kamatkar; Tsuyoshi Fukuda; Alexander A Vinks; Henry T Akinbi
Journal:  J Clin Pharmacol       Date:  2018-09-11       Impact factor: 3.126

7.  Identification, replication, and functional fine-mapping of expression quantitative trait loci in primary human liver tissue.

Authors:  Federico Innocenti; Gregory M Cooper; Ian B Stanaway; Eric R Gamazon; Joshua D Smith; Snezana Mirkov; Jacqueline Ramirez; Wanqing Liu; Yvonne S Lin; Cliona Moloney; Shelly Force Aldred; Nathan D Trinklein; Erin Schuetz; Deborah A Nickerson; Ken E Thummel; Mark J Rieder; Allan E Rettie; Mark J Ratain; Nancy J Cox; Christopher D Brown
Journal:  PLoS Genet       Date:  2011-05-26       Impact factor: 5.917

Review 8.  Nano-bio-technology and sensing chips: new systems for detection in personalized therapies and cell biology.

Authors:  Sandro Carrara
Journal:  Sensors (Basel)       Date:  2010-01-12       Impact factor: 3.576

Review 9.  Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.

Authors:  Shabbir Ahmed; Zhan Zhou; Jie Zhou; Shu-Qing Chen
Journal:  Genomics Proteomics Bioinformatics       Date:  2016-10-08       Impact factor: 7.691

Review 10.  Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods.

Authors:  Chingiz Asadov; Gunay Aliyeva; Kamala Mustafayeva
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2017-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.